PAX Labs Partners With Canadian Licensed Producers Aphria, Aurora, Organigram and Supreme Cannabis
June 10th, 2019
TORONTO, June 7, 2019 /CNW/ – PAX Labs, Inc., a leading consumer technology brand in cannabis, is pleased to announce that Aphria Inc. (“Aphria“) (TSX: APHA)(NYSE: APHA), Aurora Cannabis Inc. (“Aurora“) (TSX:ACB)(NYSE:ACB), Organigram Holdings Inc. (“Organigram“) (TSX-V: OGI)(NASDAQ: OGI), and The Supreme Cannabis Company, Inc. (“Supreme Cannabis“) (TSX: FIRE) have signed on as PAX Era brand partners. PAX designs and develops premium vaporizers for cannabis flower and concentrates. As brand partners, the licensed producers (LPs) will offer high quality products from their various brands in pods compatible with the design-forward PAX Era device. The PAX Era will be available in Canada later this year, in accordance with the legislation of cannabis extracts, edible cannabis and cannabis topicals. The PAX Era, a pen-and-pod system for cannabis concentrates, will provide consumers with a superior cannabis experience, delivering quality, control and predictability to each session.
PAX is excited to welcome these four leading LPs to the PAX Era platform, with each bringing their own unique value to Canadian consumers through a strategic partnership. Collectively, they will contribute both depth and breadth to the PAX Era experience, through a myriad of products from full-spectrum extracts to distillates and live resins, while sustaining a nationwide supply. Additionally, PAX is thrilled to share that Supreme Cannabis’ award-winning flagship brand, 7ACRES, will launch its vape products exclusively on the PAX Era platform.
“We have been working hard to ensure Canadian consumers will be able to enjoy quality cannabis concentrates in a convenient pod-format,” said Tim Pellerin, Canadian General Manager, PAX. “That is why we are excited to launch our immersive PAX Era experience with quality products from four powerhouse cannabis companies – Aphria, Aurora, Organigram and Supreme Cannabis. As the market grows, we will continue to bring on more brand partners, offering our consumers a selection of products on the PAX Era platform.”
Quotes from partners:
Megan McCrae, Vice President of Marketing, Aphria Inc.
“Aphria is thrilled to solidify a partnership with PAX. We are excited to bring our premium cannabis extracts from Solei, RIFF and our flagship medical cannabis brand, Aphria, to PAX’s innovative Era device and platform. This partnership reflects Aphria’s unwavering focus on innovation and new product offerings to meet the needs of all cannabis consumers, from novices to experienced users alike.”
Darren Karasiuk, Chief Commercial Officer, Aurora
“We are excited about the coming changes in regulation that will allow us to cover new and novel products, like those delivered through the PAX Era platform. This agreement is one of many steps Aurora is taking to be ready for the new market opportunities, and to provide our customers with ample supply and greater choice of products and delivery platforms.”
Greg Engel, Chief Executive Officer, Organigram
“Organigram and PAX share a long standing commitment to innovation. In fact, innovation is one of the founding principles of the Edison Cannabis Co. We are proud to collaborate with PAX and believe we can apply our collective expertise and product leadership to push the boundaries of enhanced consumer experiences.”
Navdeep Dhaliwal, Chief Executive Officer, Supreme Cannabis.
“As two of the most premium-focused companies in our respective fields, PAX and Supreme Cannabis are partnering together to create the ultimate vaporizing experience. Through our partnership, PAX Era users will have exclusive access to oil pods from our multi-award winning brand, 7ACRES, as well as access to pods for our other premium brands. PAX’s industry-leading vaporizers provide the best experience when paired with high-quality inputs. Consumers have raved about 7ACRES’ premium dried flower and we’re excited to make it accessible in this new form.”
ABOUT PAX LABS
PAX is a leader in the design and development of premium app-controlled vaporization technologies and devices. Headquartered in San Francisco, PAX has revolutionized the consumer experience through innovation and product design, and is committed to taking the guesswork out of cannabis with products that offer quality, transparency and predictability. PAX has sold more than 500,000 Era devices for oil concentrates and over one million devices in the flower vaporizer category globally. PAX is committed to its mission: establishing cannabis as a force for good. For more information, please visit ca.pax.com.
PAX Labs does not manufacture, produce or sell cannabis.
SOURCE PAX Labs, Inc.
For further information: Chloe Mills, [email protected], 416-459-3060
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.